newsfilter
← Latest News
GlobeNewswire·

GeoVax to Present at the 2024 BIO CEO & Investor Conference

ATLANTA, GA, Feb. 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced